Related Experiment Video
Updated: Mar 27, 2026

06:40
Collection of Human Follicular Fluid, Follicle Somatic Cells, and Immature Oocytes from Individuals Undergoing In Vitro Fertilization
Published on: October 24, 2025
1.1K
Practice patterns for expanded carrier screening among reproductive endocrinology and infertility physicians
Chloe J Denham1, Miranda L M Delawalla2, Chandler Purcell2
1Department of Gynecology and Obstetrics, Emory University, Atlanta, USA. chloe.denham@emory.edu.
Journal of Assisted Reproduction and Genetics
|March 24, 2026
Summary
Expanded carrier screening (ECS) practices vary among fertility specialists, impacting patient access to genetic testing. Standardized guidelines are needed for equitable reproductive medicine care.
Area of Science:
- Reproductive Medicine
- Medical Genetics
- Infertility Treatment
Background:
- Expanded carrier screening (ECS) is crucial for preconception genetic risk assessment.
- Interventions exist to mitigate genetic disease risks in offspring.
- Little is known about how Reproductive Endocrinology and Infertility (REI) physicians implement ECS.
Purpose of the Study:
- To assess ECS practices among U.S. REI physicians.
- To identify physician or clinic factors influencing the requirement of ECS results before fertility treatment initiation.
Main Methods:
- A 23-question survey was distributed to 802 Society for Reproductive Endocrinology and Infertility members.
- Descriptive statistics, chi-square, Fisher's exact tests, and multivariable logistic regression were used.
- Factors associated with requiring ECS results prior to treatment were analyzed.
Main Results:
- 62.2% of 143 respondents required ECS results before fertility treatment.
- Physicians trained in the West were less likely to require ECS compared to those in the Northeast (aOR: 0.29).
- Physicians in hybrid practices had higher odds of requiring ECS than those in academic settings (aOR: 6.97).
Conclusions:
- ECS practices differ among REI physicians, influenced by training region and practice setting.
- These variations may lead to unequal patient access to genetic screening.
- There is a need for standardized guidelines for ECS in reproductive medicine.

